We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in AEON Biopharma Inc in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 30 → 0 (-30)

100% less capital invested

Capital invested by funds: $3.62M → $0 (-$3.62M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 30

Holders
–
Holders Change
-30
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DKCM
Davidson Kempner Capital Management
New York
-$532K
2
LP
LMR Partners
United Kingdom
-$362K
3
AC
Athos Capital
Hong Kong
-$295K
4
WAM
Wolverine Asset Management
Illinois
-$274K
5
AC
Aristeia Capital
Connecticut
-$250K
Name Holding Trade Value Shares
Change 		Change in
Stake
DKCM
1
Davidson Kempner Capital Management
New York
– -$532K -366,671 Closed
LP
2
LMR Partners
United Kingdom
– -$362K -249,999 Closed
WAM
3
Wolverine Asset Management
Illinois
– -$274K -189,151 Closed
TCM
4
Tenor Capital Management
New York
– -$242K -166,666 Closed
AC
5
Aristeia Capital
Connecticut
– -$250K -164,255 Closed
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
– -$224K -154,432 Closed
QGA
7
Q Global Advisors
Texas
– -$192K -132,227 Closed
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
– -$145K -100,000 Closed
WA
9
Whitebox Advisors
Minnesota
– -$133K -92,000 Closed
Calamos Advisors
10
Calamos Advisors
Illinois
– -$121K -83,333 Closed
Goldman Sachs
11
Goldman Sachs
New York
– -$115K -79,526 Closed
UOC
12
UBS O'Connor
Illinois
– -$114K -74,997 Closed
KL
13
KIM LLC
Kansas
– -$91.9K -63,358 Closed
SC
14
Sculptor Capital
New York
– -$76.3K -50,040 Closed
DCM
15
Dupont Capital Management
Delaware
– -$72.5K -49,999 Closed
FCM
16
Farallon Capital Management
California
– -$72.5K -49,995 Closed
Jane Street
17
Jane Street
New York
– -$59.2K -40,825 Closed
Walleye Capital
18
Walleye Capital
New York
– -$57.3K -39,549 Closed
MCM
19
Moore Capital Management
New York
– -$48.3K -33,333 Closed
PAMP
20
Polar Asset Management Partners
Ontario, Canada
– -$41.7K -27,348 Closed
AC
21
Athos Capital
Hong Kong
– -$295K -25,417 Closed
HF
22
HRT Financial
New York
– -$27K -19,029 Closed
PC
23
Periscope Capital
Ontario, Canada
– -$22.5K -15,500 Closed
Parallax Volatility Advisers
24
Parallax Volatility Advisers
California
– -$17.6K -12,141 Closed
Walleye Trading
25
Walleye Trading
New York
– -$16.8K -11,587 Closed
1
2

AEON.WS Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q2 2024, worth a combined $0 — down 100% from $3.62M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of AEON.WS and 0 opened new positions — a net loss of 30 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Davidson Kempner Capital Management, exiting entirely with an estimated $532K sold.

  • 0 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q2 2024, down from 30 in Q1 2024.
  • Funds reported $0 of AEON Biopharma Inc stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new AEON Biopharma Inc positions in Q2 2024 and 30 closed out, a net change of -30 holders.
  • The largest AEON Biopharma Inc seller in Q2 2024 was Davidson Kempner Capital Management, an estimated $532K sold.

Based on aggregated 13F filings for Q2 2024.